메뉴 건너뛰기




Volumn 1, Issue 2, 2012, Pages 217-218

The double-edge sword effect of anti-CD73 cancer therapy

Author keywords

Adenosine; Cancer; CD73; Immunotherapy; Metastasis; Treg

Indexed keywords

5' NUCLEOTIDASE; ANTINEOPLASTIC AGENT; CD73 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

EID: 84870490220     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.1.2.18101     Document Type: Note
Times cited : (27)

References (10)
  • 1
    • 79954576658 scopus 로고    scopus 로고
    • CD73-deficient mice have increased anti-tumor immunity and are resistant to experimental metastasis
    • Stagg J, Divisekera U, Duret H, Sparwasser T, Teng MW, Darcy PK, et al. CD73-deficient mice have increased anti-tumor immunity and are resistant to experimental metastasis. Cancer Res 2011; 71:2892-900; PMID:21292811; http://dx.doi.org/10.1158/ 0008-5472.CAN-10-4246
    • (2011) Cancer Res , vol.71 , pp. 2892-2900
    • Stagg, J.1    Divisekera, U.2    Duret, H.3    Sparwasser, T.4    Teng, M.W.5    Darcy, P.K.6
  • 2
    • 75949112218 scopus 로고    scopus 로고
    • Anti-CD73 antibody therapy inhibits breast cancer tumor growth and metastasis and induces antitumor immunity
    • Stagg J, Divisekera U, McLaughlin N, Sharkey J, Pommey S, Dwyer K, et al. Anti-CD73 antibody therapy inhibits breast cancer tumor growth and metastasis and induces antitumor immunity. Proc Natl Acad Sci USA 2010; 107:1547-52; PMID:20080644; http://dx.doi. org/10.1073/pnas.0908801107
    • (2010) Proc Natl Acad Sci USA , vol.107 , pp. 1547-1552
    • Stagg, J.1    Divisekera, U.2    McLaughlin, N.3    Sharkey, J.4    Pommey, S.5    Dwyer, K.6
  • 3
    • 77957564570 scopus 로고    scopus 로고
    • Extracellular adenosine triphosphate and adenosine in cancer
    • Stagg J, Smyth MJ. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010; 29:5346-58; PMID:20661219; http://dx.doi.org/10. 1038/onc.2010.292
    • (2010) Oncogene , vol.29 , pp. 5346-5358
    • Stagg, J.1    Smyth, M.J.2
  • 4
    • 70350569295 scopus 로고    scopus 로고
    • Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors
    • Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009; 15:1170-8; PMID:19767732; http://dx.doi.org/10.1038/nm.2028
    • (2009) Nat Med , vol.15 , pp. 1170-1178
    • Ghiringhelli, F.1    Apetoh, L.2    Tesniere, A.3    Aymeric, L.4    Ma, Y.5    Ortiz, C.6
  • 5
  • 6
    • 77950231071 scopus 로고    scopus 로고
    • CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression
    • Jin D, Fan J, Wang L, Thompson LF, Liu A, Daniel BJ, et al. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res 2010; 70:2245-55; PMID: 20179192; http://dx.doi.org/10.1158/0008-5472.CAN-09-3109
    • (2010) Cancer Res , vol.70 , pp. 2245-2255
    • Jin, D.1    Fan, J.2    Wang, L.3    Thompson, L.F.4    Liu, A.5    Daniel, B.J.6
  • 7
    • 79957921286 scopus 로고    scopus 로고
    • CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
    • Wang L, Fan J, Thompson LF, Zhang Y, Shin T, Curiel T, et al. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest 2011; 121:2371-82; PMID: 21537079; http://dx.doi.org/10.1172/JCI45559
    • (2011) J Clin Invest , vol.121 , pp. 2371-2382
    • Wang, L.1    Fan, J.2    Thompson, L.F.3    Zhang, Y.4    Shin, T.5    Curiel, T.6
  • 8
    • 79955153842 scopus 로고    scopus 로고
    • Altered purinergic signaling in CD73-deficient mice inhibits tumor progression
    • Yegutkin GG, Marttila-Ichihara F, Karikoski M, Niemela J, Laurila JP, Elima K, et al. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression. Eur J Immunol 2011; 41:1231-41; PMID: 21469131; http://dx.doi.org/10.1002/eji.201041292
    • (2011) Eur J Immunol , vol.41 , pp. 1231-1241
    • Yegutkin, G.G.1    Marttila-Ichihara, F.2    Karikoski, M.3    Niemela, J.4    Laurila, J.P.5    Elima, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.